Joseph Klein III, Director at IONIS PHARMACEUTICALS INC (IONS), sold 11,518 shares at $79.45 ($910K) on 2026-07-01, disclosed to the SEC on 2026-07-06.
Scheduled sale ($910k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $79.04 | 11,419 | $903K | 99.1% |
| 2 | $79.45 | 99 | $8K | 0.9% |
| Total | $79.04 avg | 11,518 | $910K | 100% |
| Filing → |
| IONS | SELL | 2026-03-05 | $3.4M | — | Filing → |
| IONS | SELL | 2025-11-28 | $320K | — | Filing → |
| IONS | SELL | 2025-09-04 | $1.7M | — | Filing → |